Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01731015 · ClinicalTrials.gov registry record · Phase 1

Imaging Lung Function Using Oxygen Enhanced MRI

A Phase 1 study, sponsored by Hal C Charles.

Completed
Registry status
Phase 1
Development phase
15
Enrollment target

NCT01731015: Completed Phase 1 study, sponsored by Hal C Charles.

NCT01731015 is a Phase 1 study that has completed, run by Hal C Charles. The registered enrollment target is 15 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01731015, a Phase 1 study, has completed, sponsored by Hal C Charles.

COMPLETED
Registry status
Phase 1
Development phase
15 participants
Enrollment target

Study Summary

The goal of this study is to perform a pilot study to evaluate the utilization of oxygen as an inhaled contrast agent to image the airway spaces in normal and diseased human lungs to allow an effect size estimate to power future studies.

Primary Outcome

Assessment of image quality of oxygen enhanced MR images: Signal to Noise Ratio, Dynamic Range of Ratio/Difference Images

Interventions

  • DRUG Medical Grade Oxygen

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2012-01
Est. Completion 2012-09
Phase Phase 1
Hal C Charles

7 total trials

What the finished NCT01731015 record still lists

NCT01731015 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower).

The record links to 0 conditions, and to 1 intervention - of which Medical Grade Oxygen is the first listed.

NCT01731015 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01731015 about?

NCT01731015 is a clinical study titled "Imaging Lung Function Using Oxygen Enhanced MRI". The goal of this study is to perform a pilot study to evaluate the utilization of oxygen as an inhaled contrast agent to image the airway spaces in normal and diseased human lungs to allow an effect size estimate to power future studies.

What is the current status of trial NCT01731015?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2012-01. Estimated completion is 2012-09.

What interventions are being tested in trial NCT01731015?

The interventions under investigation include: Medical Grade Oxygen (DRUG).

Who is sponsoring clinical trial NCT01731015?

This trial is sponsored by Hal C Charles, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01731015's enrollment target sits among peer trials

15 1798th of 2000 higher than 157 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01731015, the US trial registry maintained by the National Library of Medicine. NCT01731015 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.